Borderline Personality Disorder: Clinical Trials

275 trials for Borderline Personality Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

140 completed, 51 unknown, 39 recruiting, 13 not yet recruiting. 176 Not applicable, 29 Phase 2, 11 Phase 1, 10 Phase 3, 7 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable176Completed 85, Unknown 39, Recruiting 27, Not yet recruiting 9, Active not recruiting 5, Withdrawn 5, Enrolling by invitation 3, Terminated 2, Suspended 1
Phase 229Completed 16, Recruiting 6, Terminated 4, Active not recruiting 2, Not yet recruiting 1
Phase 111Completed 5, Not yet recruiting 2, Recruiting 2, Terminated 1, Unknown 1
Phase 310Completed 8, Terminated 1, Withdrawn 1
Phase 47Completed 5, Unknown 1, Withdrawn 1
Early Phase 11Not yet recruiting 1

Follow Borderline Personality Disorder: new trials by email Literature Review of Borderline Personality Disorder trials Research Report on Borderline Personality Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of "DBT-LIVE", an Identity Skills Training Program, for Borderline Personality Disorder.
DBT LIVE, TAU - Treatment 1:Dialectical Behavior Therapy (DBT), Treatment as Usual
Not applicableNot yet recruitingUniversidad Europea de Valencia1122027-01-012026-07-06
ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder
Psilocybin, Psilocybin-Assisted Therapy With Dialectical Behavior Therapy - Borderline Personality Disorder, Borderline Personality Pathology
Phase 1Not yet recruitingUniversity of Minnesota182026-12-012026-09-22
Testing a Peer-led Trauma-focused Intervention for Significant Others of Those With BPD
Trauma Recovery Program (official title TBD) - Posttraumatic Stress Disorder, Family Members
Phase 1Not yet recruitingYork University602026-10-012026-07-29
Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder
IV Ketamine (0.5 mg/kg) Infusion - Two Doses Administered 24 Hours Apart for Severe Borderline Personality Disorder - Infusion of Ketamine in Severe Borderline Personality Disorder, Borderline Personality Disorder (BPD)
Phase 2Not yet recruitingUniversity Hospital, Toulouse382026-09-012026-05-12
Combining Transcranial Magnetic Stimulation With Emotion Regulation Skills Training in Borderline Personality Disorder
Transcranial Magnetic Stimulation (TMS), Emotion Regulation Skills Training - Borderline Personality Disorder (BPD)
Not applicableNot yet recruitingMassachusetts General Hospital122026-08-012026-07-20
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Ketamine Hydrochloride, Midazolam Hydrochloride, Dialectical Behavioral Therapy (DBT) - Borderline Personality Disorder (BPD), Treatment-Resistant Major Depressive Disorder
Phase 2RecruitingJoshua Rosenblat1202026-07-162026-07-29
A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder
TMS, D-Cycloserine (DCS) - Borderline Personality Disorder (BPD)
Phase 1 / Phase 2RecruitingMclean Hospital202026-06-102026-08-05
Extended Group Written Exposure Therapy for Comorbid PTSD and BPD (Traits)
Group Written Exposure Therapy - Posttraumatic Stress Disorder (PTSD), Borderline Personality Disorder (BPD)
Not applicableNot yet recruitingSt. Joseph's Healthcare Hamilton632026-06-012026-05-08
Pilot Study for the Evaluation of a New Psychotherapeutic Treatment for Borderline Personality Disorder Patients With Post-traumatic Stress Symptoms
Standard Mentalization-Based Treatment, Trauma-Focused Mentalization-Based Treatment - Borderline Personality Disorder (BPD), PTSD - Post Traumatic Stress Disorder
Not applicableNot yet recruitingEva Rüfenacht402026-06-012026-02-06
Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder
Relationship-use questionnaire - Borderline Personality Disorder, Borderline Personality Disorder (BPD)
Not applicableRecruitingUniversity Hospital, Montpellier1942026-06-012026-06-22
The Role of Gender in Borderline Personality Disorder
Borderline Personality Disorder (BPD)
RecruitingUniversity Hospital Heidelberg152026-05-292026-06-10
Pilot Study on Auricular Acupuncture in Hospitalized Adults With Borderline Personality Disorder
Auricular acupuncture program based on the N.A.D.A. protocol - Borderline Personality Disorder
Not applicableNot yet recruitingJenny Gentizon152026-04-152026-03-17
Long Term Follow-up of Mentalization-Based Treatment: Exploring Variability in Outcomes, Long-term Value and Experiences 10+ Year After Receiving MBT Day Hospital or MBT Intensive Outpatient
Borderline Personality Disorder
RecruitingDe Viersprong1132026-04-022026-09-30
Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study
Intensive Dialectical Behavior Therapy - Self-Harm, Deliberate, Suicidal Behavior
Not applicableEnrolling by invitationHaukeland University Hospital122026-03-022026-08-13
Internal Family Systems Therapy for Borderline Personality Disorder
Internal family systems therapy - Borderline Personality Disorder (BPD)
Not applicableRecruitingWaypoint Centre for Mental Health Care152026-02-012026-01-16
Physical Activity in the Management of Personality Disorders
Karate, Pedometer-based walking, Treatment as usual (TAU) - Borderline Personality Disorder (BPD), Avoidant Personality Disorders
Not applicableRecruitingJulie Midtgaard602026-02-012026-02-03
Symptom Assessment in Adolescents Placed on Child Welfare
Complex Post-Traumatic Stress Disorder (CPTSD), Borderline Personality Disorder (BPD)
RecruitingUniversity Hospital, Strasbourg, France2002026-01-302026-08-31
Home-Based tDCS for Depression in BPD
tDCS, Treatment as Usual (TAU), Psychoeducation - Major Depressive Disorder (MDD), Borderline Personality Disorders
Not applicableRecruitingCiusss de L'Est de l'Île de Montréal602026-01-012026-05-06
CULTURALLY ADAPTED DIALECTICAL BEHAVIOR THERAPY FOR LOW-MIDDLE-INCOME COUNTRIES
Culturally adapted DBT - Borderline Personality Disorder (BPD), Dialectical Behavior Therapy
Not applicableNot yet recruitingPakistan Association of Cognitive Therapists2202025-11-202025-11-28
Effectiveness of Autobiographical Rewriting Workshops on the Socio-Professional Functioning of Patients With Borderline Personality Disorder Undergoing Third-Wave Cognitive and Behavioral Therapy: A Randomized Controlled Trial
Autobiographical Rewriting Workshops, Non-specific writing workshops - Borderline Personality Disorder, Borderline Personality Disorder (BPD)
Not applicableNot yet recruitingUniversity Hospital, Montpellier1402025-10-012025-09-30

Showing 20 of 275. Sign in to see all of them.

Narrower conditions

Self-Injurious Behavior (31)  ·  Stress Disorders, Post-Traumatic (22)  ·  Suicide (21)  ·  Depression (16)  ·  Personality Disorders (16)  ·  Depressive Disorder, Major (12)  ·  Emotional Regulation (12)  ·  Bipolar Disorder (11)  ·  Anxiety Disorders (8)  ·  Impulsive Behavior (8)  ·  Attention Deficit Disorder with Hyperactivity (6)  ·  Suicide, Attempted (6)  ·  Schizophrenia (5)  ·  Suicidal Ideation (5)

Broader conditions

Mental Disorders (272)  ·  Personality Disorders (259)  ·  Behavior (77)  ·  Behavioral Symptoms (60)  ·  Trauma and Stressor Related Disorders (25)  ·  Stress Disorders, Traumatic (24)  ·  Mood Disorders (23)  ·  Social Behavior (18)  ·  Depressive Disorder (13)  ·  Self-Control (12)  ·  Bipolar and Related Disorders (11)  ·  Self-Injurious Behavior (11)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Neurodevelopmental Disorders (8)  ·  Chemically-Induced Disorders (7)

Interventions

Dialectical Behavior Therapy (21)  ·  Therapeutics (21)  ·  Transcranial Magnetic Stimulation (8)  ·  Mentalization-Based Therapy (7)  ·  Cognitive Behavioral Therapy (5)  ·  Exercise (4)  ·  Transcranial Direct Current Stimulation (4)  ·  Hydrocortisone (3)  ·  Ketamine (3)  ·  Olanzapine (3)  ·  Psychological Tests (3)  ·  Schema Therapy (3)  ·  brexpiprazole (3)  ·  Acetylcysteine (2)  ·  Citalopram (2)

Sponsors

University Hospital, Montpellier (8)  ·  University of Minnesota (7)  ·  Centre for Addiction and Mental Health (6)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (5)  ·  Icahn School of Medicine at Mount Sinai (5)  ·  University Hospital, Strasbourg, France (5)  ·  University Hospital, Toulouse (5)  ·  Yale University (5)  ·  Central Institute of Mental Health, Mannheim (4)  ·  Charite University, Berlin, Germany (4)  ·  Ciusss de L'Est de l'Île de Montréal (4)  ·  IRCCS Centro San Giovanni di Dio Fatebenefratelli (4)  ·  Mclean Hospital (4)  ·  Region Skane (4)  ·  State University of New York - Upstate Medical University (4)

Countries

United States (80)  ·  Germany (37)  ·  France (31)  ·  Canada (24)  ·  Spain (19)  ·  Denmark (10)  ·  Sweden (9)  ·  Switzerland (9)  ·  Norway (8)  ·  United Kingdom (8)  ·  Netherlands (7)  ·  Italy (6)  ·  Czechia (4)  ·  Mexico (4)  ·  Chile (3)

Top investigators

Marianne Goodman, MD (3)  ·  Alexandra Philipsen, Prof. (2)  ·  Harold Koenigsberg, MD (2)  ·  Harold W Koenigsberg, MD (2)  ·  Jon E Grant, MD, JD, MPH (2)  ·  Lars Mehlum, MD PhD (2)  ·  S. Charles Schulz, MD (2)  ·  Sarah K Fineberg, MD PhD (2)  ·  Shannon Sauer-Zavala, PhD (2)  ·  Sofie Westling, MD, PhD (2)  ·  Alessandra Minelli, Prof (1)  ·  Alex Behn, PhD (1)  ·  Alexandra Pham-Scottez, MD (1)

Results publications

PMID 32368793, PMID 36375174, PMID 33884617, PMID 21095016, PMID 22967772, PMID 39558901, PMID 40014392, PMID 10668619, PMID 11781034, PMID 14979218, PMID 16013747, PMID 17257517, PMID 18251623, PMID 19043153, PMID 19274605, PMID 19590999, PMID 19752590, PMID 19755574, PMID 19807718, PMID 20420716, PMID 20435966, PMID 20590434, PMID 21051128, PMID 21076562, PMID 21451348, PMID 21479777, PMID 21535995, PMID 22503959, PMID 22581157, PMID 23444147, PMID 24114797, PMID 24503285, PMID 24562087, PMID 24752034, PMID 24885904, PMID 25038629, PMID 25324025, PMID 25526809, PMID 25806661, PMID 25907157, PMID 26062135, PMID 26487284, PMID 26595344, PMID 26759718, PMID 26854478, PMID 26970970, PMID 27405522, PMID 27439618, PMID 27845529, PMID 27903136

NIH funding

2019 (2), R01MH061017 (2), 2002 (1), 2017 (1), 2025 (1), K23MH106648 (1), K23MH126211 (1), KL2RR025754-04 (1), R01DA014997 (1), R01MH034486 (1), R01MH063746 (1), R01MH095806 (1), R01MH129302 (1), R21MH119530 (1), R33MH125130 (1)